Tim Jasper Knotnerus
Chief Executive Officer at AgomAb Therapeutics NV
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 7 months
- Director since
- 2026
7 months of board service in total across 1 board, counting each seat separately. Longest: AgomAb Therapeutics NV, 7 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | AgomAb Therapeutics NV | Open-market purchase | +5,000 | $8.70 | $43,500 |
| Oct 5, 2026 | AgomAb Therapeutics NV | Open-market purchase | +6,000 | $8.48 | $50,880 |
Questions about Tim Jasper Knotnerus
What boards is Tim Jasper Knotnerus on?
Tim Jasper Knotnerus sits on the board of AgomAb Therapeutics NV.
What company is Tim Jasper Knotnerus the CEO of?
Tim Jasper Knotnerus has been Chief Executive Officer of AgomAb Therapeutics NV since March 2026.
How long has Tim Jasper Knotnerus served on boards?
Our records show at least 7 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.